Holen Sie sich die Stockscreener-App
216.26
0.62%
-1.35
Handel nachbörslich:
216.25
-0.010
-0.00%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
September 16, 2025 - Pharmaceutical Executive
AbbVie: Best Time To Sell In 5 Years (Rating Downgrade) (NYSE:ABBV) - Seeking Alpha
Guggenheim Reiterates a Buy Rating on AbbVie (ABBV), Sets a PT of $227 - Yahoo Finance
Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD? - sharewise.com
AbbVie (ABBV)’s Dividend Track Record: How It Became a Leader in Consistent Dividends - Yahoo Finance
With big pharma circling psychedelics, the next breakthrough may not come from tripping at all - microdose.buzz
JPMorgan Adjusts Price Target on AbbVie to $235 From $200, Maintains Overweight Rating - MarketScreener
AbbVie Settles Rinvoq Litigation, Blocks Generics Until 2037 - Law360
AbbVie's VRAYLAR® Gains Public Reimbursement In Alberta For Schizophrenia Treatment - Nasdaq
AbbVie loses appeal over Mississippi 340B state law - Endpoints News
11 Newly Overvalued Stocks for the Week - Morningstar
AbbVie Says Vraylar Antipsychotic Medication Now Listed on Alberta's Health Drug Formulary - MarketScreener
Deutsche Bank Adjusts Price Target on AbbVie to $204 From $173 - MarketScreener
AbbVie's VRAYLAR®? (Cariprazine) Now Publicly Reimbursed in Alberta - MarketScreener
Cantor Fitzgerald Adjusts AbbVie Price Target to $245 From $215, Maintains Overweight Rating - MarketScreener
Deutsche Bank Adjusts AbbVie Price Target to $204 From $173, Maintains Hold Rating - MarketScreener
AbbVie loses bid to block 340B law in Mississippi - pharmaphorum
What would a sea change in drug advertising mean for big-spending AbbVie? - Crain's Chicago Business
Barrett's Esophagus Strategic Business Report 2025-2030 Featuring 34 Companies - GlobeNewswire Inc.
Capital Market Strategies LLC Sells 1,975 Shares of AbbVie Inc. $ABBV - MarketBeat
Teamwork Financial Advisors LLC Has $595,000 Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by First Financial Bank Trust Division - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Wesbanco Bank Inc. - MarketBeat
LVM Capital Management Ltd. MI Has $31.06 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Jacobs & Co. CA Buys 1,211 Shares of AbbVie Inc. $ABBV - MarketBeat
Good Steward Wealth Advisors LLC Sells 1,932 Shares of AbbVie Inc. $ABBV - MarketBeat
Neville Rodie & Shaw Inc. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
Park National Corp OH Has $21.83 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Belpointe Asset Management LLC Sells 4,903 Shares of AbbVie Inc. $ABBV - MarketBeat
Intech Investment Management LLC Sells 90,154 Shares of AbbVie Inc. $ABBV - MarketBeat
Dynamic Technology Lab Private Ltd Invests $383,000 in AbbVie Inc. $ABBV - MarketBeat
Acadian Asset Management LLC Acquires 7,640 Shares of AbbVie Inc. $ABBV - MarketBeat
Fortis Capital Advisors LLC Has $993,000 Stock Position in AbbVie Inc. $ABBV - MarketBeat
Blue Rock Wealth Management LLC Buys New Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Thurston Springer Miller Herd & Titak Inc. - MarketBeat
TruWealth Advisors LLC Has $26.46 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
McAdam LLC Reduces Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Ransom Advisory Ltd Acquires Shares of 13,215 AbbVie Inc. $ABBV - MarketBeat
Integrity Alliance LLC. Purchases 20,680 Shares of AbbVie Inc. $ABBV - MarketBeat
IFM Investors Pty Ltd Purchases 3,741 Shares of AbbVie Inc. $ABBV - MarketBeat
Glenview Trust co Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Anchor Investment Management LLC Reduces Stake in AbbVie Inc. $ABBV - MarketBeat
Focus Partners Wealth Has $112.77 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $260.00 at Wells Fargo & Company - MarketBeat
AbbVie (NYSE:ABBV) Given New $240.00 Price Target at BMO Capital Markets - MarketBeat
AbbVie (ABBV) Receives a Buy from Guggenheim - The Globe and Mail
William Blair Forecasts AbbVie's FY2027 Earnings (NYSE:ABBV) - MarketBeat
Guinness Asset Management LTD Trims Stock Position in AbbVie Inc. $ABBV - MarketBeat
Swedbank AB Lowers Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Voya Investment Management LLC Has $544.72 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
0.53%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):